Your search for supplemental oxygen returned 10 results

Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO

Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity

Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

The studies evaluated routine clinical practice data from more than 800 hospitals in the US.

Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.

InflaRx is working to increase supply of the product in the US as quickly as possible.

High-dose inhaled nitric oxide linked to more days free from oxygen supplementation, shorter ICU and hospital length of stay

Patients with COVID-19 who required low-flow oxygen supplementation were randomly assigned to receive either SNG001 (n=314) or placebo (n=309) once daily for 14 days.

Rates of severe disease low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies